Anshan Hifichem Co., Ltd. (300758.SZ)
Anshan, CN
Anshan Hifichem Co., Ltd., an enterprise established in 2006 and headquartered in Anshan, China, specializes in the innovation, production, and sale of advanced organic pigments, solvent dyes, and chemical intermediates across the Chinese market. The company caters to a diverse array of sectors, including printing inks, protective coatings, plastics, and electronics, as well as niche applications such as paper and agricultural seed coloration.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.99% | -14.52% | -4.05% | -26.34% | -3.69% | +0.71% | -17.34% | +27.42% | -1.99% | +22.88% | +22.88% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-4.6% Q1'26: +9.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-51.6% Q1'26: -50.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-13.6% Q1'26: +0.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+7.3% Q1'26: +8.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.4% Q1'26: +4.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+1.2% Q1'26: +2.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.90× Q1'26: 6.71× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
694.58M
est: 723.00M (-3.9%)
|
1.01B
est: 959.00M (+5.1%)
|
1.47B
est.
|
1.35B
est: 1.31B (+2.7%)
|
1.21B
est: 1.46B (-17.2%)
|
1.22B
est: 1.46B (-16.6%)
|
1.57B
est: 1.60B (-2.1%)
|
1.50B
est: 1.67B (-10.5%)
|
1.67B
1.67B – 1.67B
-0.1% YoY
|
1.86B
1.86B – 1.86B
+11.5% YoY
|
2.07B
2.07B – 2.07B
+11.2% YoY
|
| EBITDA |
160.92M
est: 147.67M (+9.0%)
|
278.51M
est: 195.88M (+42.2%)
|
299.43M
est.
|
320.89M
est: 267.98M (+19.7%)
|
147.91M
est: 298.21M (-50.4%)
|
181.06M
est: 298.21M (-39.3%)
|
327.25M
est: 286.70M (+14.1%)
|
265.20M
est: 299.06M (-11.3%)
|
298.70M
298.70M – 298.70M
-0.1% YoY
|
332.90M
332.90M – 332.90M
+11.5% YoY
|
370.15M
370.15M – 370.15M
+11.2% YoY
|
| EBIT |
126.77M
est: 82.29M (+54.1%)
|
222.24M
est: 109.15M (+103.6%)
|
166.86M
est.
|
237.10M
est: 149.33M (+58.8%)
|
27.04M
est: 166.17M (-83.7%)
|
44.03M
est: 166.17M (-73.5%)
|
186.25M
est: 136.49M (+36.5%)
|
109.03M
est: 142.37M (-23.4%)
|
142.20M
142.20M – 142.20M
-0.1% YoY
|
158.48M
158.48M – 158.48M
+11.5% YoY
|
176.22M
176.22M – 176.22M
+11.2% YoY
|
| Net Income |
108.10M
est: 133.02M (-18.7%)
|
175.46M
est: 232.32M (-24.5%)
|
260.77M
est.
|
179.97M
est: 32.24M (+458.2%)
|
-2.79M
est: 56.42M (-105.0%)
|
11.00M
est: 56.42M (-80.5%)
|
124.93M
est: 175.31M (-28.7%)
|
61.16M
est: 110.08M (-44.4%)
|
93.77M
93.77M – 93.77M
-14.8% YoY
|
138.62M
138.62M – 138.62M
+47.8% YoY
|
175.31M
175.31M – 175.31M
+26.5% YoY
|
| SGA |
69.58M
est: 44.75M (+55.5%)
|
84.57M
est: 59.36M (+42.5%)
|
90.74M
est.
|
135.28M
est: 81.21M (+66.6%)
|
187.59M
est: 90.37M (+107.6%)
|
180.50M
est: 90.37M (+99.7%)
|
202.71M
est: 188.35M (+7.6%)
|
82.33M
est: 196.46M (-58.1%)
|
196.23M
196.23M – 196.23M
-0.1% YoY
|
218.70M
218.70M – 218.70M
+11.5% YoY
|
243.17M
243.17M – 243.17M
+11.2% YoY
|
| EPS |
0.35
est: 0.33 (+6.0%)
|
0.54
est: 0.58 (-6.3%)
|
0.65
est.
|
0.46
est: 0.08 (+475.0%)
|
-0.01
est: 0.14 (-107.1%)
|
0.03
est: 0.14 (-78.6%)
|
0.31
est: 0.43 (-27.9%)
|
0.15
est: 0.27 (-44.4%)
|
0.23
0.23 – 0.23
-14.8% YoY
|
0.34
0.34 – 0.34
+47.8% YoY
|
0.43
0.43 – 0.43
+26.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 81.1K | 0.39% |
| 2 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 58.1K | 0.29% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bei Zhang | Accounting Supervisor | — | — |
| Ting Da Gao | Deputy GM & Secretary to the Board | — | male |
| Xuebo Qi | GM & Director | — | male |
| Zhi Qiao | Deputy GM & Non-Independent Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300758.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
